COLL: Bathi saben saham sajrone rolas wulan pungkasan Collegium Pharmaceutical Inc

Collegium Pharmaceutical (COLL) profitability relies on patent protection and the sale of non-opioid medications. The trailing 12-month earnings per share trend demonstrates financial stability, where the parameter value equals 0.98. Management efficiency is evident in the successful acquisition of niche drugs, while commitment to ESG principles is reflected in strict distribution control and the eco-friendly disposal of chemical waste during production.

COLL (Collegium Pharmaceutical) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 14.11.2026

Collegium Pharma - rincian analitis lan metrik utama (COLL)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Collegium Pharmaceutical|COLL - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Nilai pasar Collegium Pharmaceutical, Inc.|COLL - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Buku saben Saham Collegium Pharmaceutical|COLL - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku collegiumpharma.com|COLL - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Collegium Pharmaceutical|COLL - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Collegium Pharmaceutical Inc|COLL - Utang perusahaan|Utang-utang marang kapitalisasi buku Collegium Pharmaceutical, Inc.|COLL - Utang jangka dawa|Utang jangka cendhak perusahaan Collegium Pharmaceutical|Rasio cepet collegiumpharma.com

- indikator pendapatan resik lan kelipatan nilai:

COLL - Asil keuangan resik|Bathi mangsa ngarep Collegium Pharmaceutical|COLL - Pangali P/E|Rega marang bathi mangsa ngarep Collegium Pharmaceutical, Inc.|COLL - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Collegium Pharmaceutical, Inc.|COLL - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Collegium Pharmaceutical|COLL - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan collegiumpharma.com|COLL - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Collegium Pharmaceutical

- rincian pendapatan lan dodolan:

COLL - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Collegium Pharmaceutical|COLL - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang prakiraan pendapatan Collegium Pharmaceutical, Inc.

Pambiji fundamental perusahaan:Collegium Pharmaceutical (COLL)

Produk seri Collegium Pharmaceutical Inc

Earnings per share (EPS TTM) measures the ultimate efficiency of the business by allocating total annual income, net of all expenses, per common share. By analyzing the trailing twelve-month earnings per share, an investor assesses the ability of Collegium Pharmaceutical (COLL) to monetize its unique abuse-deterrent drug delivery system, which creates high market barriers for competitors.

Pesaing utama